Support That Lasts: Momcozy Ergowrap Belly Band for Long-Term Postpartum Care
New York, NY, June 10, 2025 (GLOBE NEWSWIRE) -- Momcozy, a maternal wellness brand trusted by over 3.6 million families globally, reframes postpartum care with the Momcozy Ergowrap Postpartum Belly Band. Unlike conventional waist binders, this professional support gear delivers lasting comfort and core reinforcement for mothers navigating the ongoing physical demands of parenting.
With its patented Ergonest Support Structure™, the belly band distributes lower back pressure to reduce strain during daily tasks like nursing, caregiving, or desk work. It also encourages posture alignment and aids recovery of abdominal and core muscles. Designed for ease of wear and subtlety, its breathable, skin-friendly materials ensure discreet, all-day comfort—whether lifting a toddler, running errands or returning to the office.
Designed for Daily Recovery—Not Just the Early Days
While many belly bands emphasize shaping or compression, the Momcozy belly band focuses on recovery and support that evolves with a mother's needs. Its clinically guided design addresses common postpartum concerns including:
Ongoing back discomfort
Diastasis recti
Weakened core stability
Pelvic misalignment
'This isn't about shaping—it's about sustainable, everyday support,' said a Momcozy spokesperson. 'Recovery doesn't end after six weeks; it's a long-term journey.'
Why Mothers Use the Ergowrap Beyond Initial Recovery
Mothers using the Ergowrap postpartum belly band consistently highlight how it integrates into real-life routines—supporting recovery without disrupting daily tasks.
Claire, a verified user, said, 'It's incredibly easy to put on and take off, which is exactly what you need when you're running on two hours of sleep. It hugs the body and supports the back without feeling stiff.'
Sapna shared a similar experience: 'It helped me sit up straighter and reduced strain on my back during work. Super comfy—supportive but not overtight.'
Lyndsey, now 7.5 months postpartum, added, 'I wore it during a three-hour car ride yesterday and it felt great. It stays in place—even now.'
Built for Comfort and Long-Term FunctionalityThe Momcozy Ergowrap integrates technical design features that adapt to evolving postpartum needs, addressing common physical stressors during routine activity, caregiving and recovery.
Ergonest Support Structure™: Reinforces lumbar support, easing back pressure during caregiving or extended sitting.
3D Abdomen Lifting Design: Provides elevation for the belly while gently compressing, aiding uterine repositioning and diastasis recti recovery.
Breathable, Skin-Friendly Materials: Latex-free and ventilated to prevent moisture buildup during extended wear.
Customizable Fit: Available in petite (M–XL) and standard (M–2XL) sizes with self-gripping closures for easy adjustment.
Discreet, Stylish Look: Offered in black, oyster pink and gray for seamless integration into daily wardrobes.
This postpartum essential blends ergonomic support with comfort and versatility—enabling mothers to move, heal, and manage routines with confidence.
A Long-Term Essential for Daily Recovery
The Momcozy Ergowrap Postpartum Belly Band isn't just for early healing—it's a long-term solution that supports mothers through varied phases of recovery and caregiving. Whether heading back to work or juggling daily chores, the Ergowrap serves as a reliable back wrap that reduces discomfort and promotes alignment.
Its adaptability makes it an ideal item for gift ideas, postpartum care kits, hospital bags or baby registries. As the understanding of postpartum recovery evolves, so too must the tools that support it.
For additional details, visit the Momcozy Ergowrap Postpartum Belly Band product page.
About Momcozy
Momcozy is a maternal wellness brand supporting over 3.6 million families worldwide. The company designs comfort-driven, clinically informed products that empower mothers through pregnancy and postpartum recovery. By integrating medical insights and real-life feedback, Momcozy offers meaningful solutions that promote healing, bonding and confidence at every stage. Learn more at https://www.momcozy.com
CONTACT: Anna Jiang Momcozy pr-at-momcozy.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Upturn
a day ago
- Business Upturn
KIF18A Targeting Therapies FDA EMA Approval Clinical Trials By Indication Company Country Drug Class Report
Delhi, July 12, 2025 (GLOBE NEWSWIRE) — Global KIF18A Targeting Therapies Market Trends, Clinical Trials, Technology Platforms & Future Outlook 2025 Report Highlights & Findings: First KIF18A Targeting Therapy Commercial Availability Expected By 2030 Highest Phase Of Development: Phase-I/II KIF18A Targeting Therapies In Clinical Trials: > 10 Therapies KIF18A Targeting Therapies Clinical Trials Insight By Company, Country, Indication & Phase KIF18A Targeting Therapies Market Development Trends Insight KIF18A Therapies Technology Platforms Insight Download Report: The global KIF18A targeting therapies market is rapidly gathering momentum as KIF18A has emerged as a key vulnerability in cancers characterized by chromosomal instability. As a mitotic kinesin motor protein essential for chromosome alignment during cell division, KIF18A is overexpressed in malignancies such as ovarian and triple-negative breast cancers, making it a promising target for precision oncology with potentially lower toxicity than traditional chemotherapies. Although no KIF18A-targeted therapy is commercially available yet, the field is progressing quickly. Clinical pipelines include more than 10 therapies, with several in early clinical development. Among the frontrunners is ATX‑295 from Accent Therapeutics, an oral, best-in-class small-molecule inhibitor that recently entered a Phase I/II dose-escalation study in patients with advanced solid tumors, including ovarian and triple-negative breast cancer. It's employed with biomarker-enriched enrollment based on genomic instability markers like whole-genome doubling, and has received FDA Fast Track status—accelerating its path forward. The clinical landscape includes global contributions from leading biotechs such as Volastra Therapeutics, advancing multiple small-molecule inhibitors including Sovilnesib (AMG‑650) in Phase I for platinum-resistant ovarian cancer, and VLS‑1488 in Phase I/II across chromosomal instability-high tumors. Accent's ATX‑295 stands currently at the most advanced Phase I/II stage, with trials in the US and potentially Asia-Pacific, suggesting geographic development convergence. Technological innovation underpins expansion in this field. Development is dominated by small-molecule inhibitors designed to halt KIF18A's motor activity at kinetochores, causing mitotic catastrophe in cancer cells. Alternative approaches include disrupting upstream regulatory pathways like phosphorylation, and leveraging AI-driven drug discovery platforms. For example, Insilico Medicine's Chemistry42 and PandaOmics platforms generated a macrocyclic KIF18A inhibitor (ISM9682), showcasing the power of AI to enhance specificity and efficiency in drug design. Market trends demonstrate strong growth potential. The first commercial KIF18A-targeting therapy is expected by 2030, propelled by fast track designations and positive preclinical data. The rich pipeline, combined with precision biomarker strategies, supports a robust developmental roadmap, aligning with unmet clinical needs in CIN-high solid tumors and potentially extending to hematologic malignancies where KIF18A overexpression correlates with poor prognosis. Regional development trends show clinical leadership based in the US and Europe, where companies like Accent and Volastra are active, while China and other Asia-Pacific markets are engaging through global trial participation and local biotech collaborations. Multi-region trial footprints and biomarker-defined patient enrollment strategies are shaping global development dynamics. Our Global KIF18A Targeting Therapies Market Report offers detailed insights into this evolving therapeutic area. It profiles more than ten clinical-stage candidates by company, indication, country, and development phase, with a deep focus on ATX‑295 as the leading Phase I/II program. The report evaluates technology platforms, including small-molecule motor inhibitors and AI-enabled discovery, and analyzes biomarker-led patient selection models. Regional development trends and regulatory environments are mapped, and strategic partnerships and investments are examined. For pharmaceutical executives, biotech investors, and drug development leaders, this report provides a strategic foundation. It outlines market drivers, technological innovations, and clinical milestones that are poised to transform KIF18A from a promising target into an approved therapeutic by 2030, potentially offering new treatment options for patients with chromosomally unstable tumors. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash


Business Upturn
a day ago
- Business Upturn
Dr. Anosh Ahmed Foundation Announces Aid for Texas Flood Victims Through America First Foundation
Chicago, IL, July 12, 2025 (GLOBE NEWSWIRE) — In response to the recent floods impacting communities across Texas, Dr. Anosh Ahmed, physician and founder of the Anosh Supports America First Foundation, has announced a relief initiative aimed at assisting affected families. The initiative will include direct financial assistance, support for grieving families, and home reconstruction efforts for uninsured residents Standing with Texas As rising waters displace thousands across the state, Dr. Anosh Ahmed has activated his foundation's emergency response team to work with local authorities and communities hardest hit by the disaster. His support will focus on: Direct financial assistance to families who have lost loved ones to families who have lost loved ones Shelter and essential supplies for displaced residents for displaced residents Home rebuilding assistance for uninsured families for uninsured families Collaboration with churches, community organizations, and first responders to ensure effective outreach 'When Americans suffer, we don't wait — we act,' said Dr. Anosh Ahmed. 'This is not just about recovery. It's about restoring dignity and security for our fellow citizens.' America First in Action Founded earlier this year, the Anosh Supports America First Foundation was created to uphold and support the pillars of American strength — the military, law enforcement including members of Department of Justice and ex-FBI agents and their families, first responders, and patriotic communities. Dr. Anosh Ahmed's latest move expands that mission into disaster relief, reinforcing his belief that helping those in need is one of the most American acts of all. 'Being a proud Republican and believer in America First means stepping up when our people need help — not just with words, but with real action,' he added. Rebuilding Lives, Not Just Structures Dr. Anosh Ahmed's Texas relief plan includes long-term support beyond the initial recovery. His foundation will: Fund home reconstruction for uninsured families Provide mental health and grief counseling resources Support first responders and veterans affected by the disaster Launch community rebuilding initiatives focused on resilience and preparedness A special 'Texas Strong: America First Gala' will be hosted by the foundation in Dallas to raise additional funds and awareness. Supporting Those Who Serve Dr. Ahmed emphasized that veterans, police officers, and military families will be given priority in the foundation's housing and aid programs. His long-standing appreciation for America's protectors is at the heart of every initiative he undertakes. 'Our heroes in uniform deserve more than just our thanks—they deserve action. This relief effort will ensure they are not left behind,' Dr. Anosh Ahmed stated. About Dr. Anosh Ahmed Dr. Anosh Ahmed is a physician, entrepreneur, and Republican philanthropist dedicated to the principles of service, patriotism, and community. Through his Anosh Supports America First Foundation , he works to uplift those who serve and strengthen American communities in times of need. #anoshAhmed #dranoshahmed #anoshahmedMD #dranoshahmedchicago #anoshahmedofficial #anoshIncfoundation #anoshahmedleadership #anoshahmedbook Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash


Business Upturn
2 days ago
- Business Upturn
Clarification on Leadership Announcement: Annette Slyman not to join Life Backup Plan as Chief Operating Officer
Aliso Viejo, CA, July 11, 2025 (GLOBE NEWSWIRE) — Galacxia, Inc., the developer of the Life Backup Plan app, is issuing a clarification to our July 10, 2025 press release. Annette Slyman will not be joining the team in any capacity, due to extenuating circumstances. Plans evolve. Our mission stays the course. We continue to hold Ms. Slyman in the highest regard. Galacxia remains committed to delivering innovative digital health and safety solutions that improve lives and support communities nationwide. About Life Backup Plan by Galacxia, Inc. Life Backup Plan is an end-to-end safety, emergency detection, digital health and multi-faceted care app that reduces tragedies, improves outcomes, lowers medical costs, and eases the burden on families and the healthcare system. Unlike other health and personal safety systems that require pressing a button to summon help, Life Backup Plan proactively checks on people, shares critical health data, coordinates support, and handles everything from emergency response to long-term caregiving, end-of-life planning, and daily logistics. We're delivering a comprehensive solution that bridges fragmented systems, supports value-based care, and brings modern tools into a system still largely reliant on fax machines.. Galacxia, Inc. is a SBA certified Woman-Owned Small Business and Delaware C Corporation committed to transforming personal safety, emergency response, and health access and equity. Eyes on the stars. Hands on the wheel. Heart in the mission. Press inquiries Life Backup Plan by Galacxia, Inc Sandy Eulitt [email protected] 8588480860 49 El Prado Lane, Oceanside, CA 92058